Funded Tech Companies
Indapta Therapeutics
Indapta Therapeutics, based in San Francisco, received equity investments through Lonza Group AG, Leaps by Bayer and RA Capital.
Company Overview
Company Name
Indapta Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Indapta is a biotechnology company seeking to harness the natural power of the immune system to fight hematologic and solid cancers with our universal G-NK cell platform. Headquartered in San Francisco, Indapta was founded in 2017 by Guy DiPierro along with Ronald Martell and scientists at the University of California, Davis, and Stanford University.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
2/24/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Ronald Martell
Chief Executive Officer
Mark Frohlich
VP - Bus. Development
Guy Dipierro
VP - Bus. Development
Lori Kunkel
VP - R & D
Austin Bigley
VP - Regulatory Affairs
Elana Van Oudenaren
Company Investors
- Lonza Group AG
- Leaps by Bayer (Fabio Pucci)
- RA Capital (Laura Stoppel)
- Vertex Ventures HC (Lori Hu)
- Myeloma Investment Fund
Browse more funded tech companies:
Incysus Therapeutics | InDebted
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs